emia). With pathological neonatal jaundice, there is an increased risk for developing bilirubin-induced neurologic dysfunction (BIND), such as acute bilirubin encephalopathy, and its sequelae, kernicterus [1] . Because unbound bilirubin, which is bilirubin not bound to albumin (Alb), easily enters the brain, serum unbound bilirubin concentration (UB) has been reported to be a better index than total bilirubin concentration (TB) for identifying infants at risk for developing BIND in recent experimental and clinical studies [2] [3] [4] [5] [6] . Therefore, the management of newborns with hyperbilirubinemia using the measurement of serum UB has attracted much interest in recent years to prevent BIND [2] .
The mass action relationship between serum UB, TB, and Alb concentrations, and the binding constant [2, 7] . Alb and K are highly variable in newborns. In particular, Alb binding for bilirubin is a crucial determinant of UB, and a reduction in Alb may lead to a higher UB in serum [2, 7] . Therefore, hypoalbuminemia in newborns within 1 week after birth may carry a major risk of a high serum UB. Serum Alb concentrations are known to be significantly reduced following abdominal operation in adults [8, 9] . In newborns, hypoalbuminemia also occurs after an abdominal operation. However, there are no reports that have clarified the changes in serum Alb concentrations in newborns before and after abdominal operation soon after birth. Moreover, there are no studies about the impact of hypoalbuminemia following abdominal surgery on serum bilirubin binding in newborns soon after birth.
The purpose of this study was to determine whether the lower serum Alb concentration occurring in newborns undergoing abdominal surgery shortly after birth is sufficient to cause higher serum UB compared with nonsurgical newborns who have similar serum TB.
Materials and Methods

Study Design and Patient Groups
For this retrospective matched case-control study, we reviewed the medical charts of term and late-preterm newborn patients who were hospitalized at Kobe University Hospital between January 2006 and September 2008 with the approval of the ethical committee of Kobe University Graduate School of Medicine. Fifteen newborns born at 6 34 weeks' gestation who underwent abdominal operation within 3 days after birth (surgery group) were enrolled in the study. The 15 enrolled patients were all newborns who underwent abdominal operation at that age during the study period in our hospital. The diseases for all these newborns were congenital abnormalities of the gastrointestinal tract: four duodenal atresias, four intestinal atresias, three anorectal anomalies, two malrotations, one Hirschsprung's disease, and one esophageal atresia. The confirmed diagnosis of congenital abnormalities of the gastrointestinal tract was made by the operative findings or pathological findings of extirpated sections. All of the newborns in the surgery group were treated with some type of medication (cephazolin, cefmetazole, furosemide, famotidine, phenobarbital, and/or fentanyl citrate, but not intralipid, Alb, or fresh frozen plasma) before, during, and/or after their operations. Three of 15 newborns in the surgery group developed clinical jaundice. Pathologic causes of jaundice, such as blood group incompatibility, red blood cell enzyme abnormalities, red blood cell membrane defects, extravascular blood, polycythemia, hormonal deficiencies, or bilirubin-metabolism disorders, were not found in these patients. They also had no family history or clinical findings of hyperlipemia.
The control group consisted of 30 newborns who did not undergo any operations, including term and late-preterm newborns who were healthy or not severely sick. The control group was randomly chosen from 919 infants cared for in a level II transitional care nursery or well-baby nursery of Kobe University Hospital, and matched for gestational age, birth weight, and sex with those in the surgery group.
Clinical and laboratory data, including the serum UB, TB, direct bilirubin (DB), and Alb concentrations, UB/TB ratio, and K were compared between groups. Furthermore, pre-and postoperative serum Alb concentrations were evaluated in the surgery group.
Measurement of the Serum UB, TB, DB, and Alb Concentrations
For all newborns who are cared for in our hospital, both serum UB and TB are routinely measured after informed consent of the parents of the newborns and assessed for the management of neonatal hyperbilirubinemia. In all surgery patients, serum UB, TB, DB, and Alb concentrations were measured on same blood sample before and soon after operation, and then every 12-24 h until at least 7 days after birth. In control newborns, they were measured at 0, 1, 4, 5, and 7 days after birth.
Serum TB and UB were measured by an automated UB analyzer (Arrows Co., Ltd., Osaka, Japan), using spectrophotometry and the glucose oxidase-peroxidase method, respectively, as previously described [10, 11] . Serum TB and UB were displayed in mg/dl (1 mg/dl = 17.1 M ) and in g/dl (1 g/dl = 17.1 n M ), respectively. Serum UB was measured at a single peroxidase concentration. Serum Alb concentrations and serum DB were measured using the modified bromocresol purple method and the bilirubin oxidase method, respectively [12, 13] .
Calculation of UB/TB Ratio and K
The UB/TB ratio and K were calculated using the following equations:
The distribution of the bilirubin pool between the various compartments depends on the number of binding sites in each compartment and their affinity for binding bilirubin which is quantified by a K [2] . The UB is the free fraction of unconjugated bilirubin combined with not only Alb, but also erythrocyte mem-brane, lipoprotein and others in blood. Of these carriers, Alb is the main carrier for bilirubin with a high K [2] .
The relationship between serum UB, Alb, and 
Results
Clinical Characteristics in Enrolled Patients
Clinical characteristics in the surgery and control groups are shown in table 1 . The control group included 30 newborns; there were 15 healthy newborns, 12 with transient tachypnea of the newborn, one with transient hypoglycemia, one with meconium aspiration syndrome with mild symptoms, and one newborn delivered from a mother with systemic lupus erythematosus. Gestational age, birth weight, gender and Apgar scores were similar in both groups. When preoperative serum TB in the surgery group was compared with serum TB at the same age in the control group, preoperative serum TB was a little higher than that in the control group, but the difference was not significant. There were no significant differences in age at the maximum serum UB between the groups. All of the 15 newborn patients in the surgery group had infusion therapy, whereas approximately half of the patients in the control group had infusion therapy. Fluids with glucose and electrolytes were used for infusion therapy in both groups. No significant differences were observed in body weight changes at the age of maximum serum UB, although there were significant differences in the rates of infusion therapy between the groups.
There were no differences in gestational age, birth weight, gender, and serum UB and TB between control newborns who had infusion therapy and those who did not have therapy (data not shown). There was no significant difference in serum Alb concentrations in control newborns with infusion therapy before and after infusion therapy [3.5 g/dl (3.2-4.0 g/dl) vs. 3.6 g/dl (3.1 to 4.1 g/dl), p = not significant (n.s.)].
As expected, the age at beginning of feeding and age at enteral feeding at 100 ml/kg/day were significantly later in the surgery group than those in the control group (p ! 0.001 and p ! 0.001, respectively). Four of 15 newborns (27%) in the surgery group and 27 of 30 newborns (90%) in the control group were receiving breast milk. 
Maximum Serum UB
The serum UB in the surgery group was significantly higher than that in the control group (p ! 0.02; fig. 1 a) . The number of newborns with a serum UB greater than 1.0 g/dl was higher (4/15, 27%) in the surgery group than that in the control group (1/30, 3%; p ! 0.05).
Serum TB, UB/TB Ratio, and Serum Alb Concentrations at the Age of Maximum Serum UB
We compared the serum TB, UB/TB ratio, and serum Alb concentrations between the surgery and control groups at the age of maximum serum UB ( fig. 1 b-d) . No significant differences were found in serum TB between the groups. In the surgery group, the UB/TB ratio was significantly higher than that in the control group (p ! 0.001). In contrast, serum Alb concentrations in the surgery group were significantly lower than those in the control group (p ! 0.001).
K and Serum DB at the Age of Maximum Serum UB
No significant differences were found in K and serum DB between the groups ( table 2 ). Serum DB was less than 2 mg/dl in all newborns of the surgery and control groups.
Pre-and Postoperative Serum Alb Concentrations
Thirteen of 15 patients in the surgery group (87%) had a reduction in postoperative serum Alb concentrations compared with preoperative values ( fig. 2 ) . Median se- , UB/TB ratio, and serum Alb concentrations in each group are expressed as median (range). Serum UB in the surgery group was significantly higher than that in the control group (p ! 0.02). In the surgery group, the UB/TB ratio, but not serum TB, was significantly higher than that in the control group (serum TB: p = n.s., UB/TB ratio: p ! 0.001). In contrast, serum Alb concentrations were significantly lower in the surgery group than those in the control group (p ! 0.001). rum Alb concentrations in the surgery group were significantly reduced from 3.4 g/dl (1.8-4.2 g/dl) before operation to 2.7 g/dl (2.0 to 3.2 g/dl) after operation (p ! 0.001). However, there were no changes in median serum Alb concentrations from 0 to 5 days after birth in the control group [0 days after birth: 3.7 g/dl (3.1-4.4 g/dl) vs. 5 days after birth: 3.6 g/dl (3.2-4.1 g/dl), p = n.s.].
Discussion
The results of this study suggest that at a given serum TB, serum UB will be higher in jaundiced, postabdominal surgery patients if they are hypoalbuminemic. Therefore, low serum Alb concentrations following abdominal surgery require special attention when interpreting the risk of TB, and TB/Alb ratio is critical in estimating serum UB unless serum UB can be measured directly.
Bowel obstructions are known to cause high serum TB via increased enterohepatic circulation [14] . It has been shown that fasting increases serum bilirubin [15] . In our study, pre-and postoperative serum TB in the surgery group was not significant higher than that at the same age in the control group ( table 1 ; fig. 1 ). However, the total body bilirubin load in the surgery group should have increased at the age of maximum serum UB, because operated newborns have a transient decrease in peristalsis and continue to fast postoperatively, and bilirubin as well as Alb are moved into extravascular spaces with a fall in the vascular TB after operation. The increased total body bilirubin load after operation may also have an impact on increased serum UB. Furthermore, the location of the lesion may be related to high TB [16] . When our 15 enrolled surgery patients were classified by anatomical diagnosis, serum TB of newborns with the upper bowel obstruction was higher than that of newborns with the lower bowel obstruction (data not shown). Because these data were from a small survey in our single center, further studies using a larger group of operated newborns due to congenital abnormalities of the gastrointestinal tract are needed to draw this conclusion.
In general, serum UB peaks at approximately 4 days after birth in Japanese newborns [6] . Our enrolled newborns in the surgery and control groups also reached peak concentrations of serum UB at 4 and 5 days, respectively, after birth ( table 1 ) . The serum TB in the surgery group ordinarily would not raise concern. However, because these newborns have relatively higher serum UB at any given serum TB, BIND may be of concern at serum TB below conventional guidelines for intervention for newborns undergoing abdominal surgery. Therefore, abdominal surgery should be included in the lists of conditions considered to place newborns at increased risk for BIND.
The UB analyzer occasionally shows higher values when serum DB exceeds 2 mg/dl, and lower values when there is a large quantity of vitamin C in the reaction system; its antioxidative effect interferes with bilirubin oxidation by peroxidase [6] . In all enrolled newborns in this study, serum DB was less than 2 mg/dl. None of the enrolled newborns had a large quantity of vitamin C. Therefore, we believe that the serum UB in this study was a reliable measurement.
Previous reports have shown that fasting does not cause reduction in serum Alb concentrations, even though there is a sharp decrease in Alb serum concentrations within a couple of days after an abdominal operation [9, 17] . Sixteen of 30 cases in the control group had infusion therapy for several reasons in this study. We found that newborns with infusion therapy did not have any significant differences in serum Alb concentrations before and after infusion therapy. Therefore, we concluded that infusion therapy does not contribute to large reductions in serum Alb concentrations. Our results showed clear evidence that serum Alb concentrations are reduced in newborns after abdominal operation soon after birth ( fig. 2 ) . We found that postoperative hypoalbuminemia appears not only in adults but also in newborns soon after birth [8] . Critical illness after major surgical stress generally alters the distribution of Alb between the intravascular and extravascular components [8, 9, 17] . Hypoalbuminemia after surgical operation is related to loss of intravascular Alb due to capillary leakage, and not hepatic dysfunction or poor nutritional status [9, 17] . Although K is often lower in sick newborns [2] , we did not find a decrease in K in the surgery group.
The limitations of our study are as follows: (1) the influence of bilirubin displacers and other carriers of bilirubin has not been investigated; (2) the peroxidase method with a single peroxidase concentration using the UB analyzer may underestimate serum UB, and (3) this is a retrospective study with a small number of newborns who underwent abdominal operation soon after birth.
Some medications that have been reported as bilirubin displacers were used in newborns in the surgery group, i.e. cefazolin, cefmetazole, furosemide, and phenobarbital [5] . Because ACTH and cortisol may increase due to the stress of an operation, free fatty acid, one of the bilirubin displacers, may increase in serum. Bilirubin is combined with not only Alb but also erythrocyte membrane, lipoprotein and others in blood. Further studies about the influence of these bilirubin displacers and other carriers of bilirubin are required to determine whether there is a significant increase in serum UB in newborns following abdominal operation soon after birth. Recently, Ahlfors et al. [18] reported that the peroxidase method with a single peroxidase concentration increasingly underestimates serum UB as the serum UB increases. In order to check the accuracy of the serum UB in samples, the reanalyses using two peroxidase concentrations should be needed. Prospective studies using a larger group of newborns with abdominal operation soon after birth are needed to confirm the conclusions of this study.
Conclusion
This study has shown for the first time that at any given serum TB, serum UB may be higher in jaundiced, postabdominal surgery patients if they are hypoalbuminemic. These findings suggest that newborns who have undergone abdominal operation soon after birth have an increased risk of developing BIND.
